NCT06255340View on ClinicalTrials.gov

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

August 28, 2024

Study Completion Date

August 28, 2024

Conditions
Healthy
Interventions
DRUG

BI 3031185

BI 3031185

DRUG

Placebo matching BI 3031185

Placebo

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY